Bicistronic expression plasmid encoding allergen and anti-IgE single chain variable fragment antibody as a novel DNA vaccine for allergy therapy and prevention

Medical Hypotheses

Volumn 67, Issue 1, 2006, Pages 71-74

  Bandbon Balenga, Nariman Aghaei ^a   Thalhamer, Josef ^b   Weiss, Richard ^b  

^a UNIVERSITY OF TEHRAN   (Iran)

^b UNIVERSITY OF SALZBURG   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN G;

ALLERGY; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; BASOPHIL; CLONAL ANERGY; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTERNAL RIBOSOME ENTRY SITE; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENES; HUMANS; HYPERSENSITIVITY; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN VARIABLE REGION; MODELS, BIOLOGICAL; PLASMIDS; RATS; VACCINES, DNA;

EID: 33646076463     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.12.044     Document Type: Article

References (11)

1. Janeway C.A., Travers P., and Walport M. Immunobiology: the immune system in health and disease. 4th ed. (1999), Elsevier Science Ltd., London
2. Carter S.E., and Patts-Mills T.A. Searching for the cause of the increase in asthma. Curr Opin Pediatr 10 (1998) 594-599
3. Lundback B. Epidemiology of rhinitis and asthma. Clin Exp Allergy 28 Suppl. 2 (1998) 3-10
4. Raz E., Tighe H., Sato Y., et al. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci USA 93 (1996) 5141-5145
5. Weiss R., Hammerl P., Hartl A., et al. Design of protective and therapeutic DNA vaccines for the treatment of allergic diseases. Curr Drug Targets Inflamm Allergy 4 5 (2005) 585-597
6. Chang TW. Treating hypersensitivities with anti-IgE monoclonal antibodies that bind to IgE-expressing B cells but not to basophils, 1996. US Patent 5, 543, 144.
7. Chang T.W., Davis F.M., Sun N.C., Sun C.R.Y., MacGlashan D.W., and Hamilton R.G. Monoclonal antibodies specific for human IgE-producing B cells: a potential therapeutic for IgE-mediated allergic diseases. Bio/Technol 8 (1990) 122-126
8. Bialy H. Can antibodies to IgE act as anti-allergics?. Bio/Technol 8 (1990) 96-100
9. Chang T.W. The pharmacological basis of anti-IgE therapy. Nat Biotechnol 18 (2000) 157-162
10. Wild J., Gruner B., Metzger K., et al. Polyvalent vaccination against hepatitis B surface and core antigen using a dicistronic expression plasmid. Vaccine 16 4 (1998) 353-360
11. Hartl A., Weiss R., Hochreiter R., Scheiblhofer S., and Thalhamer J. DNA vaccines for allergy treatment. Methods 32 3 (2004) 328-339